Clinical Trials
Study Title:
A Phase 2 Open Label Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination with Ruxolitinib in Subjects with Myelofibrosis (REFINE)
For more information about the trial above please contact the study team:
|